Novel fragment-based QSAR modeling and combinatorial design of pyrazole-derived CRK3 inhibitors as potent antileishmanials.
The CRK3 cyclin-dependent kinase of Leishmania plays an important role in regulating the cell-cycle progression at the G2/M phase checkpoint transition, proliferation, and viability inside the host macrophage. In this study, a novel fragment-based QSAR model has been developed using 22 pyrazole-derived compounds exhibiting inhibitory activity against Leishmanial CRK3. Unlike other QSAR methods, this fragment-based method gives flexibility to study the relationship between molecular fragments of interest and their contribution for the variation in the biological response by evaluating cross-term fragment descriptors. Based on the fragment-based QSAR model, a combinatorial library was generated, and top two compounds were reported after predicting their activity. The QSAR model showed satisfactory statistical parameters for the data set (r(2) = 0.8752, q(2) = 0.6690, F-ratio = 30.37, and pred_r(2) = 0.8632) with four descriptors describing the nature of substituent groups and the environment of the substitution site. Evaluation of the model implied that electron-rich substitution at R1 position improves the inhibitory activity, while decline in inhibitory activity was observed in presence of nitrogen at R2 position. The analysis carried out in this study provides a substantial basis for consideration of the designed pyrazole-based leads as potent antileishmanial drugs.
Apaji Institute of Mathematics & Applied Computer Technology, Banasthali University, Tonk, 304022, India.
Sukriti
S
Goyal
Jaspreet K
JK
Dhanjal
Chetna
C
Tyagi
Manisha
M
Goyal
Abhinav
A
Grover
D000981:Antiprotozoal Agents / Q000737:chemistry* / Q000494:pharmacology; D018844:Cyclin-Dependent Kinases / Q000037:antagonists & inhibitors* / Q000378:metabolism; D015195:Drug Design; D006801:Humans; D007891:Leishmania / Q000187:drug effects / Q000201:enzymology*; D007896:Leishmaniasis / Q000188:drug therapy / Q000201:enzymology / Q000469:parasitology; D008958:Models, Molecular; D047428:Protein Kinase Inhibitors / Q000737:chemistry* / Q000494:pharmacology; D011720:Pyrazoles / Q000737:chemistry* / Q000494:pharmacology; D021281:Quantitative Structure-Activity Relationship
D000981:Antiprotozoal Agents; D047428:Protein Kinase Inhibitors; D011720:Pyrazoles; C031280:pyrazole; D018844:Cyclin-Dependent Kinases
CRK3; GQSAR; Leishmania; QSAR; combinatorial library; leishmaniasis